Study of QLM2010 in healthy adults
Part of Digestive system clinical trials.
This early-stage study tests a new medicine called QLM2010 to see how the body absorbs it. It's for healthy adults and will help determine the right dose for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Weight must be at least 45 kg for women and 50 kg for men, with a BMI between 18 and 30.
- You must be generally healthy, with no significant medical conditions or abnormal lab results.
- You must be willing to use effective birth control during the study and for 3 months after.
- You must not have allergies to common allergens like soy, eggs, milk, or certain drugs.
- You cannot have taken certain medications, supplements, or have smoked more than 5 cigarettes a day recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
This trial tests whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can better prevent nausea and vomiting caused by Trastuzumab Rezetecan. If you are starting this cancer treatment, you may be able to join.
This study tests an anti-nausea drug (nano-crystalline megestrol acetate) to see if it helps prevent nausea and vomiting caused by chemotherapy in people with stomach cancer. If you are starting your first chemotherapy, this may help you feel better during treatment.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
This study tests an investigational drug called QLM2011 for people with advanced or metastatic solid tumors that have not responded to standard treatments or for which no standard treatment exists. The goal is to see if the drug is safe and effective.
This study tests a new medicine (QLS2319) to see if it’s safe and can help people with cancer-related weight loss and muscle loss (cachexia). It’s for people whose daily activities aren’t severely limited by their cancer.
Hear when a new Chemotherapy-Induced Nausea and Vomiting (CINV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.